maleimide has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Z; Sun, J; Sun, M; Wei, W; Yang, J | 1 |
| He, Z; Kan, Q; Kou, L; Li, D; Li, J; Li, Q; Li, Z; Liu, J; Liu, X; Luo, C; Sun, J; Sun, Y; Wang, Y; Zhang, D; Zhang, H; Zhang, P; Zhao, S | 1 |
| Grobmyer, SR; Jiang, H; Qian, W; Xi, L; Yang, L; Zhou, G | 1 |
3 other study(ies) available for maleimide and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Cytosine arabinoside prodrug designed to bind plasma serum albumin for drug delivery.
Topics: Administration, Intravenous; Animals; Caproates; Cell Line, Tumor; Circular Dichroism; Cytarabine; Drug Delivery Systems; Drug Design; Female; Maleimides; Mammary Neoplasms, Experimental; Mice; Molecular Docking Simulation; Prodrugs; Serum Albumin; Xenograft Model Antitumor Assays | 2018 |
In situ low-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy.
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Survival; Drug Liberation; Female; Maleimides; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; NIH 3T3 Cells; Polyethylene Glycols; Polyglactin 910; Protein Corona; Rats, Sprague-Dawley; Serum Albumin | 2018 |
Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents.
Topics: Animals; Cell Line, Tumor; Coloring Agents; Contrast Media; Ferric Compounds; Gene Expression Regulation, Neoplastic; Infrared Rays; Magnets; Maleimides; Mammary Neoplasms, Experimental; Mice; Nanoparticles; Photoacoustic Techniques; Receptors, Urokinase Plasminogen Activator; Tomography | 2014 |